With the Centers for Medicare & Medicaid Services’ (CMS) Advance Notice and the CY 2027 Medicare Advantage and Part D Final Rate Announcement now finalized, regulatory direction is clear. CMS has provided consistent signals through both early policy guidance and final rulemaking. Together, these actions confirm a decisive shift away from retrospective, clean up driven approaches and toward prospective, encounter anchored, defensible risk adjustment as the industry standard for Medicare Advantage organizations nationwide.
This shift extends beyond risk adjustment alone. CMS has aligned expectations across quality performance, audit oversight, and operational accountability, reinforcing that future success will depend on execution, documentation integrity, and traceability embedded into daily workflows.
CMS direction is now confirmed through final policy
The Advance Notice signaled tightening expectations around documentation standards, risk accuracy, and operational precision. The Final Rate Announcement removed remaining ambiguity by finalizing policies that materially limit reliance on retrospective recovery, even as CMS confirmed a 2.48 percent net Medicare Advantage payment increase for 2027.
CMS also emphasized that revenue growth alone will not offset operational inefficiency. Performance will increasingly depend on defensible data, consistent clinical documentation, and integrated execution across risk, quality, and compliance functions.
Why retrospective risk adjustment is no longer viable
Several finalized policies directly constrain retrospective risk adjustment strategies. CMS confirmed the exclusion of diagnoses derived from unlinked chart review records beginning in CY 2027 and finalized the exclusion of diagnoses captured solely through audio only telehealth encounters.
These changes reinforce CMS’ expectation that risk adjustment be grounded in verifiable, encounter based clinical evidence. Retrospective approaches that rely on downstream chart recovery or post submission reconciliation now face increased financial and audit exposure.
CMS has positioned documentation traceability and encounter linkage as foundational requirements rather than optional best practices. Retrospective recovery can no longer compensate for upstream gaps in documentation or workflow execution.
As a result of these finalized policies, Medicare Advantage plans are facing a narrower set of viable operating paths, including:
- Greater reliance on encounter-based documentation rather than retrospective recovery
- Increased scrutiny of diagnosis traceability and source validity
- Higher audit exposure tied to documentation gaps rather than coding volume
- Stronger alignment between risk adjustment, Star Ratings performance, and Risk Adjustment Data Validation (RADV) readiness
Prospective risk adjustment as an operating model
Prospective risk adjustment is no longer a tactical enhancement. CMS policy now treats it as a comprehensive operating model that requires risk identification, documentation preparation, and validation to occur before and during the clinical encounter rather than after submission.
This model prioritizes encounter anchored capture, provider workflow integration, and documentation readiness at the point of care. CMS expectations increasingly link risk adjustment success to broader performance outcomes, including Star Ratings performance and audit defensibility.
Success is no longer defined by risk score maximization alone. It is defined by what can be supported, traced, and defended across the full lifecycle from identification through audit.
Risk, quality, and audit readiness are converging
CMS guidance also signals a convergence of risk adjustment, Star Ratings, and RADV audit readiness. Historically, these functions have often been managed in silos with separate tools, timelines, and governance structures.
CMS policy now rejects that separation. Risk accuracy, quality outcomes, and audit readiness all depend on documentation integrity, encounter linkage, and operational coordination. Fragmented workflows increase exposure across all three areas, while integrated models improve consistency and defensibility.
This convergence was reinforced by finalized CMS guidance emphasizing that audit readiness and prospective execution must be embedded into everyday operations.
What this means for plans preparing for 2027 and beyond
As Medicare Advantage organizations plan for upcoming contract years, the implications extend beyond compliance teams. Decisions related to operating model design, data governance, and workflow integration will directly influence financial performance and regulatory resilience, as outlined in the CY 2027 Medicare Advantage and Part D Final Rate Announcement.
From compliance to competitive advantage
CMS has clarified its expectations. Accuracy is required. Documentation must be defensible. Quality must be operationalized. Integration is essential.
Plans that respond proactively will move beyond reactive compliance and toward durable competitive advantage. The future of Medicare Advantage will reward organizations that build connected, prospective, data driven performance operations now.
Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system.